BAY885
CAS No. 2307249-33-6
BAY885( —— )
Catalog No. M24050 CAS No. 2307249-33-6
BAY885 is a new ERK5 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 223 | In Stock |
|
| 5MG | 335 | In Stock |
|
| 10MG | 500 | In Stock |
|
| 25MG | 806 | In Stock |
|
| 50MG | 1098 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBAY885
-
NoteResearch use only, not for human use.
-
Brief DescriptionBAY885 is a new ERK5 inhibitor.
-
DescriptionBAY885 is a new ERK5 inhibitor.
-
In VitroThe ERK5 probe 41 (BAY-885) showed potent ERK5 kinase and transcriptional inhibition in the SN12C-MEF2 reporter cell line (IC50 = 115 nM/IC90 = 691 nM) and had no effects on a reporter control cell line with constitutive luciferase expression (SN12C-CMV-luc, IC50 > 30 μM).
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
TargetERK
-
RecptorERK5
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2307249-33-6
-
Formula Weight515.53
-
Molecular FormulaC25H28F3N7O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:16.67 mg/mL (32.34 mM; Need ultrasonic)
-
SMILESCN1CCN(CC1)C2=CC3=C(C(=NC=N3)C4CCN(CC4)C(=O)C5=C(C=C(C=C5)OC(F)(F)F)N)N=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nguyen D, et al. Discovery and Characterization of the Potent and Highly Selective (Piperidin-4-yl)pyrido[3,2- d]pyrimidine Based in Vitro Probe BAY-885 for the Kinase ERK5. J Med Chem. 2019 Jan 24;62(2):928-940.
molnova catalog
related products
-
ERK5-IN-2
ERK5-IN-2 is an orally active sub-micromolar selective ERK5 inhibitor with IC50s of 0.82 μM 3 μM for ERK5 and ERK5 MEF2D respectively.
-
ERK-IN-4
ERK-IN-4 is a cell-permeable ERK inhibitor with potential antiproliferative effects for the study of diseases caused by immune dysfunction.
-
CAFESTOL
CAFESTOL is a ERK inhibitor for AP-1-targeted activity against PGE2 production and the mRNA expression of cyclooxygenase (COX)-2 in LPS-activated RAW264.7 cells.?Cafestol has strong inhibitory activity on PGE2 production by suppressing the NF-kB activation pathway.
Cart
sales@molnova.com